Sverker Hasselblom

Summary

Affiliation: Sahlgrenska University Hospital
Country: Sweden

Publications

  1. ncbi The number of tumour-infiltrating TIA-1+ cytotoxic T cells but not FOXP3+ regulatory T cells predicts outcome in diffuse large B-cell lymphoma
    Sverker Hasselblom
    Section of Haematology and Coagulation, Department of Internal Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Br J Haematol 137:364-73. 2007
  2. doi High immunohistochemical expression of p-AKT predicts inferior survival in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
    Sverker Hasselblom
    Section of Haematology and Coagulation, Department of Internal Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden
    Br J Haematol 149:560-8. 2010
  3. ncbi The impact of gender, age and patient selection on prognosis and outcome in diffuse large B-cell lymphoma - a population-based study
    Sverker Hasselblom
    Department of Medicine, Section of Haematology and Coagulation, Sahlgrenska University Hospital, Goteborg, Sweden
    Leuk Lymphoma 48:736-45. 2007
  4. doi Low rather than high Ki-67 protein expression is an adverse prognostic factor in diffuse large B-cell lymphoma
    Sverker Hasselblom
    Department of Internal Medicine, Section of Haematology and Coagulation, Goteborg, Sweden
    Leuk Lymphoma 49:1501-9. 2008
  5. doi Expression of CD68+ tumor-associated macrophages in patients with diffuse large B-cell lymphoma and its relation to prognosis
    Sverker Hasselblom
    Section of Haematology and Coagulation, Department of Internal Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Pathol Int 58:529-32. 2008
  6. doi Improved outcome for very elderly patients with diffuse large B-cell lymphoma in the immunochemotherapy era
    Sverker Hasselblom
    Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Leuk Lymphoma 53:394-9. 2012
  7. ncbi Testicular lymphoma--a retrospective, population-based, clinical and immunohistochemical study
    Sverker Hasselblom
    Haematology and Coagulation Section, Department of Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Acta Oncol 43:758-65. 2004
  8. ncbi Evaluation of clinical staging in chronic lymphocytic leukemia- population-based study
    Peter Apelgren
    Section of Haematology and Coagulation, Department of Internal Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Leuk Lymphoma 47:2505-16. 2006
  9. ncbi The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL)
    Katarina Junevik
    Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Ann Hematol 86:89-94. 2007
  10. doi Serum nuclear magnetic resonance-based metabolomics and outcome in diffuse large B-cell lymphoma patients - a pilot study
    Martin Stenson
    a Section of Hematology, Department of Medicine, Kungälvs Hospital, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Leuk Lymphoma 57:1814-22. 2016

Collaborators

  • Hans Wedel
  • Per Ola Andersson
  • Herman Nilsson-Ehle
  • Martin Stenson
  • Katarina Junevik
  • Olle Werlenius
  • Peter Apelgren
  • Rui Pinto
  • Bengt Göran Karlsson
  • Anders Pedersen
  • Stefan Jacobsson

Detail Information

Publications10

  1. ncbi The number of tumour-infiltrating TIA-1+ cytotoxic T cells but not FOXP3+ regulatory T cells predicts outcome in diffuse large B-cell lymphoma
    Sverker Hasselblom
    Section of Haematology and Coagulation, Department of Internal Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Br J Haematol 137:364-73. 2007
    ..The lack of correlation between the number of FOXP3+ cells and survival could possibly indicate that tumour-infiltrating T(regs) are of less clinical importance in DLBCL. However, these findings need to be explored in functional studies...
  2. doi High immunohistochemical expression of p-AKT predicts inferior survival in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
    Sverker Hasselblom
    Section of Haematology and Coagulation, Department of Internal Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden
    Br J Haematol 149:560-8. 2010
    ..In addition, bcl-2 status could have prognostic importance also in the era of immunochemotherapy...
  3. ncbi The impact of gender, age and patient selection on prognosis and outcome in diffuse large B-cell lymphoma - a population-based study
    Sverker Hasselblom
    Department of Medicine, Section of Haematology and Coagulation, Sahlgrenska University Hospital, Goteborg, Sweden
    Leuk Lymphoma 48:736-45. 2007
    ..As men had lower PFS and OS than women, it seems important that gender perspective be taken into account in future studies...
  4. doi Low rather than high Ki-67 protein expression is an adverse prognostic factor in diffuse large B-cell lymphoma
    Sverker Hasselblom
    Department of Internal Medicine, Section of Haematology and Coagulation, Goteborg, Sweden
    Leuk Lymphoma 49:1501-9. 2008
    ..Together, these results suggest that low rather than high Ki-67 protein expression is of prognostic importance in DLBCL...
  5. doi Expression of CD68+ tumor-associated macrophages in patients with diffuse large B-cell lymphoma and its relation to prognosis
    Sverker Hasselblom
    Section of Haematology and Coagulation, Department of Internal Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Pathol Int 58:529-32. 2008
    ..94). These data indicate that the pro-tumor effect of TAM has limited clinical relevance in DLBCL patients, which could imply that therapeutic strategies aimed at enhancing their anti-tumor activity are of continuous clinical interest...
  6. doi Improved outcome for very elderly patients with diffuse large B-cell lymphoma in the immunochemotherapy era
    Sverker Hasselblom
    Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Leuk Lymphoma 53:394-9. 2012
    ..In conclusion, moderately reduced R-CHOP is tolerable and effective for a considerable number of very elderly patients with DLBCL and high age by itself should not be a reason for excluding a patient with DLBCL from such treatment...
  7. ncbi Testicular lymphoma--a retrospective, population-based, clinical and immunohistochemical study
    Sverker Hasselblom
    Haematology and Coagulation Section, Department of Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Acta Oncol 43:758-65. 2004
    ..A high intratumoural microvessel density was correlated with a high degree of Ki-67 positive tumour cells and an inferior overall survival...
  8. ncbi Evaluation of clinical staging in chronic lymphocytic leukemia- population-based study
    Peter Apelgren
    Section of Haematology and Coagulation, Department of Internal Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Leuk Lymphoma 47:2505-16. 2006
    ..Finally, in both systems, low stage patients had inferior survival compared to age- and sex-matched controls. Our data emphasize the need for a new risk stratification system for CLL patients...
  9. ncbi The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL)
    Katarina Junevik
    Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Ann Hematol 86:89-94. 2007
    ..Our results suggest that increased expression of KIR and CD94 on CTL in advanced stage B-CLL may potentially contribute to the impaired anti-tumour immune response in these patients...
  10. doi Serum nuclear magnetic resonance-based metabolomics and outcome in diffuse large B-cell lymphoma patients - a pilot study
    Martin Stenson
    a Section of Hematology, Department of Medicine, Kungälvs Hospital, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Leuk Lymphoma 57:1814-22. 2016
    ....